The rulebook for rare disease treatments will be overhauled to make it quicker and easier to get these therapies tested, ...

Swiss pharma major Roche (ROG: SIX) has reported positive Phase III data for Gazyva (obinutuzumab) in systemic lupus ...

Irish healthcare group Uniphar (LSE: UPR) has unified its US businesses under one banner, rebranding RRD Biopharma ...

UK-based specialty CNS-focused pharma company CNX Therapeutics says it has acquired the global Sativex (nabiximols) business ...

Pharmacovigilance (PV) is a crucial process used by pharmaceutical companies, healthcare professionals and regulators in identifying, evaluating and preventing adverse drug reactions.

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to challenge multinational dominance.

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

Shares in UK pharma major GSK were 6% higher late Wednesday after the London-based drugmaker presented its third quarter ...

Germany-based biotech Tubulis today announced a second and final closing of its Series C round totaling 344 million euros ...

US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...

German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...

US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...